Evoke Pharma Inc - Common Stock, par value $0.0001 per share (EVOK) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2024 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
EVOK
Shares outstanding
1,552,381
Price per share
$10.80
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
590,713
Total reported value
$2,937,342
% of total 13F portfolios
0%
Share change
+358,691
Value change
+$1,814,237
Number of holders
15
Price from insider filings
$10.80
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Evoke Pharma Inc - Common Stock, par value $0.0001 per share (EVOK) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Klein Roger M. 10% $810,110 163,000 Klein Roger M. 04 Nov 2025
LYTTON LAURENCE W 3.9% $138,479 61,274 Lytton, Laurence W. 31 Mar 2025
MORGAN STANLEY 0% -95% $331 -$1,749,814 31 -100% Morgan Stanley 30 Nov 2025

As of 30 Sep 2025, 15 institutional investors reported holding 590,713 shares of Evoke Pharma Inc - Common Stock, par value $0.0001 per share (EVOK). This represents 38% of the company’s total 1,552,381 outstanding shares.

Top 17 Institutional Shareholders

The largest institutional shareholders of Evoke Pharma Inc - Common Stock, par value $0.0001 per share (EVOK) together control 38% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
MORGAN STANLEY 10% 159,358 +248897% 0% $792,009
Nantahala Capital Management, LLC 9.5% 148,153 0% 0.05% $736,320
Bleichroeder LP 9.4% 146,395 +113% 0.14% $727,583
National Wealth Management Group, LLC 5.2% 80,130 0.15% $398,246
DRW Securities, LLC 1.5% 23,742 0.01% $117,997
VANGUARD GROUP INC 1.2% 18,759 0% $93,233
TWO SIGMA SECURITIES, LLC 0.67% 10,437 0.01% $51,872
OSAIC HOLDINGS, INC. 0.19% 3,010 0% $16,403
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 0.02% 272 0% $1,352
ROYAL BANK OF CANADA 0.01% 190 0% $1,000
BlackRock, Inc. 0.01% 122 0% 0% $606
SBI Securities Co., Ltd. 0% 76 +1.3% 0% $378
Tower Research Capital LLC (TRC) 0% 40 -98% 0% $199
NewEdge Advisors, LLC 0% 17 0% 0% $84
BANK OF AMERICA CORP /DE/ 0% 12 +20% 0% $60
FMR LLC 0% 0 -100% $0
CITADEL ADVISORS LLC 0% 0 -100% $0

Institutional Holders of Evoke Pharma Inc - Common Stock, par value $0.0001 per share (EVOK) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$398,246 $10.80 0
2025 Q3 590,713 $2,937,342 +$1,814,237 $4.97 15
2025 Q2 232,022 $603,642 -$26,836 $2.60 10
2025 Q1 242,206 $666,068 +$63,212 $2.75 9
2024 Q4 218,456 $965,575 +$13,287 $4.42 8
2024 Q3 208,317 $994,552 +$993,972 $4.76 11